Cargando…
Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
BACKGROUND: Although conbercept has been used for other diseases associated with new vascular formation, the effect of single-dose conbercept in combination with proliferative diabetic retinopathy (PDR) have not been established. We thus conducted this protocol for systematic review and meta-analysi...
Autores principales: | Wang, Liangyu, Chen, Zhaoli, Wang, Xiaoxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084045/ https://www.ncbi.nlm.nih.gov/pubmed/33907112 http://dx.doi.org/10.1097/MD.0000000000025611 |
Ejemplares similares
-
Efficacy of conbercept combined with panretinal photocoagulation in the treatment of proliferative diabetic retinopathy
por: He, Feng, et al.
Publicado: (2020) -
Clinical efficacy of intravitreal aflibercept injection versus vitrectomy with panretinal photocoagulation for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Hu, Yao, et al.
Publicado: (2021) -
Clinical efficacy of anti-vascular endothelial growth factor versus panretinal photocoagulation for patients with proliferative diabetic retinopathy: A protocol for systematic review and meta-analysis
por: Lin, Yuxian, et al.
Publicado: (2021) -
The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis
por: Huang, Chao, et al.
Publicado: (2021) -
A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
por: Sun, Yaoyao, et al.
Publicado: (2023)